Fujin technology provides a new simple, non-invasive, and accessible method to support the early detection of lung cancer. Today, a large proportion of cases are still diagnosed at an advanced stage, when treatments are more difficult, more expensive, and often less effective. The objective of the project is to better understand the information present in human breath and to assess whether certain biomarkers may, over time, help identify risk profiles and support medical decision-making.